« Back
Home /
Antagonist G

Antagonist G

Manufacturer	GenScript
Category	Oncology Neuroscience Protein Aggregation, Clearance & Misfolding Peptides & Proteins Peptides By Organ Lung Cancer
Type	Peptides
Specific against	other
Amount	0.5mg
Item no.	RP10174-0.5
Targets	SCLC1, CTSA
eClass 6.1	34160400
eClass 9.0	32160409
Available
C-Terminal	NH2
Description	Antagonist G is a broad-spectrum neuropeptide growth factor antagonist that inhibits the growth of small cell lung cancer (SCLC) cells both in vitro and in vivo. It is metabolized in peripheral tissues by a chymotrypsin-like serine carboxypeptidase causing C-terminal deamidation and removal of the methionine residue. The metabolites of Antagonist G retain neuropeptide antagonist properties and are thought to contribute to the parent peptide's antitumor activity.
Storage	Store at -20C. Keep tightly closed. Store in a cool dry place.
Product Origin	USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.5mg

available

Delivery expected until 5/9/2024